PPARG and hepatocellular carcinoma: In summary, we identified a previously undescribed signaling pathway of the USP22-PPARγ-ACLY/ACC axis that plays an important role in lipogenesis and HCC tumorigenesis and provides an option for cancer therapy targeting fatty acid synthesis.